The global infectious disease molecular diagnostics market is on a remarkable growth trajectory, valued at USD 35.87 billion in 2024. This growth is driven by factors such as the aging global population, an increasing incidence of infectious diseases, and continual advancements in diagnostic technology. The market is expected to grow at a compound annual growth rate (CAGR) of 3.20% from 2025 to...